At the 2023 American Society of Hematology (ASH) Annual Meeting in San Diego, California, Oncology Data Advisor had the privilege of speaking with many distinguished clinicians and patient advocates about their research presented at the meeting. This podcast series features exclusive conversations on breaking data for novel therapies, technological innovations in hematology/oncology, efforts to reduce disparities and improve health equity, and more!

Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD

Click here to view the full article on Oncology Data Advisor: https://oncdata.com/mary-pasquinelli-sybil-ai 

In this episode of Exploring AI in Oncology, Dr. Waqas Haque speaks with Mary Pasquinelli, DNP, Nurse Practitioner and Director of the Lung Screening Program at the University of Illinois (UI) Health, about the evolving role of screening and artificial intelligence (AI) in lung cancer detection. Their conversation spans program design, health equity, AI validation in diverse populations, multimodal detection with circulating tumor DNA (ctDNA) and imaging, and practical strategies that boost adherence and impact in both academic and community settings.

Improving Early and Equitable Lung Cancer Detection With Sybil: Mary Pasquinelli, DNP, FNP-BC, CTTS, and Waqas Haque

Time is running out to access this essential CME/NCPD-approved podcast! Join renowned dermatology experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold as they dive into the latest evidence and best practices for treating atopic dermatitis in children and adolescents. With new therapies rapidly changing the treatment landscape, this podcast delivers the practical insights you need to confidently diagnose, evaluate, and manage pediatric atopic dermatitis.

Don’t miss your chance to:

-Get up to speed on novel and emerging therapies, including nonsteroidal topicals, JAK inhibitors, and monoclonal antibodies
-Learn how to recognize key clinical features that inform the differential diagnosis
-Discover strategies to optimize outcomes and quality of life for your young patients

This activity is expiring soon—listen now to stay current and earn credit before it’s gone!

Click here to claim your CME/NCPD credit: https://bit.ly/4nGZhBG

EXPIRING SOON! Best Practices & Breakthroughs in Pediatric Atopic Dermatitis

Time is running out to access this essential CME/NCPD-approved podcast! Join renowned dermatology experts Dr. Peter A. Lio and Dr. Linda F. Stein Gold as they dive into the latest evidence and best practices for treating atopic dermatitis in children and adolescents. With new therapies rapidly changing the treatment landscape, this podcast delivers the practical insights you need to confidently diagnose, evaluate, and manage pediatric atopic dermatitis.

Don’t miss your chance to:

-Get up to speed on novel and emerging therapies, including nonsteroidal topicals, JAK inhibitors, and monoclonal antibodies
-Learn how to recognize key clinical features that inform the differential diagnosis
-Discover strategies to optimize outcomes and quality of life for your young patients

This activity is expiring soon—listen now to stay current and earn credit before it’s gone!

Click here to claim your CME/NCPD credit: bit.ly/4nGZhBG

LAST CHANCE – Expires November 21!

Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.


Listen now and earn 0.5 CME credit: https://bit.ly/49GyP5T

EXPIRING SOON! Diagnosis and Management of Dedifferentiated Liposarcoma

LAST CHANCE – Expires November 21!

Dedifferentiated liposarcoma (DDLPS) poses significant challenges for diagnosis and management. In this expert‑led discussion, Dr. Richard F. Riedel (Duke University Medical Center) and Dr. Candace L. Haddox (Dana‑Farber Cancer Institute, Harvard Medical School) share practical insights on identifying MDM2/CDK4 amplification, exploring emerging treatments such as CDK4/6 inhibitors and immunotherapies, and improving outcomes through a multidisciplinary approach.

Listen now and earn 0.5 CME credit: bit.ly/49GyP5T

Stay ahead in NSCLC management with this accredited podcast! HER2 alterations, including gene mutations and protein overexpression, are key therapeutic targets, but their complexity can challenge treatment decisions.

In Module 1 of this podcast, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, provides essential insights and testing recommendations to optimize patient care. Listen now!

Click here to claim CME/NCPD credit: bit.ly/49NCaQu

EXPIRING SOON! What’s New With HER2: Charting New Paths in NSCLC Care - Module 1: Actionable Insights and Testing Recommendations

Stay ahead in NSCLC management with our accredited podccast! HER2 alterations, including gene amplifications, mutations, and protein overexpression, are critical therapeutic targets, but their heterogeneity can complicate treatment strategies.

In Module 2, Dr. Julia Kathleen Rotow, Clinical Director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute and Assistant Professor of Medicine at Harvard Medical School, explores advanced testing methodologies and strategies to navigate HER2 complexities and optimize patient outcomes. Listen now!

Click here to claim CME/NCPD credit: bit.ly/405xEJO

EXPIRING SOON! What’s New With HER2: Charting New Paths in NSCLC Care - Module 2: Current and Emerging Treatments for HER2-Mutated NSCLC

The mission of Oncology Data Advisor is to provide the multidisciplinary team with expert insights into clinical best practices and research progress in cancer care.

Reducing Stigmatizing Language in the EMR for More Equitable Care: Alex Boucher, MD

Oncology Data Advisor®